Virtu Financial LLC Global Blood Therapeutics, Inc. Transaction History

Virtu Financial LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$25.48 - $37.34 $386,709 - $566,709	-15,177 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$32.46 - $43.42 $492,645 - $658,985	15,177 New	15,177 $531,000
Q1 2021 May 19, 2021	SELL	$38.94 - $50.85 $236,521 - $308,862	-6,074 Closed	0 $0
Q4 2020 Feb 24, 2021	SELL	$37.65 - $63.77 $9,111 - $15,432	-242 Reduced 3.83%	6,074 $263,000
Q3 2020 Dec 11, 2020	SELL	$52.76 - $74.49 $173,896 - $245,519	-3,296 Reduced 34.29%	6,316 $348,000
Q2 2020 Aug 07, 2020	BUY	$48.73 - $81.82 $198,038 - $332,516	4,064 Added 73.25%	9,612 $607,000
Q4 2019 Feb 04, 2020	SELL	$45.7 - $81.86 $201,582 - $361,084	-4,411 Reduced 44.29%	5,548 $441,000
Q3 2019 Nov 20, 2019	SELL	$45.35 - $57.91 $328,651 - $419,673	-7,247 Reduced 42.12%	9,959 $483,000
Q2 2019 Aug 13, 2019	BUY	$52.6 - $63.29 $659,183 - $793,150	12,532 Added 268.12%	17,206 $905,000
Q1 2019 Apr 12, 2019	BUY	$39.99 - $53.48 $186,913 - $249,965	4,674 New	4,674 $247,000
Q4 2018 Jan 16, 2019	SELL	$31.54 - $46.67 $764,561 - $1.13 Million	-24,241 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$38.0 - $51.1 $921,158 - $1.24 Million	24,241 New	24,241 $921,000
Q2 2018 Jul 30, 2018	SELL	$38.7 - $50.15 $222,408 - $288,212	-5,747 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$38.7 - $50.15 $23,800 - $30,842	615 Added 11.98%	5,747 $260,000
Q1 2018 May 14, 2018	BUY	$39.6 - $65.9 $203,227 - $338,198	5,132 New	5,132 $248,000
Q4 2017 Feb 09, 2018	SELL	$29.7 - $45.7 $340,065 - $523,265	-11,450 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$25.1 - $31.05 $287,395 - $355,522	11,450	11,450 $0

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.